GlassScriptPhysician profile
John M Goldberg
NPI 1154349322
$3,786.67
in general payments reported to CMS, 2019-2025
38 companies · $70.44 in 2025
The $70.44 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.74 · 2020: $45.38 · 2021: $392 · 2022: $909 · 2023: $1,205 · 2024: $1,110 · 2025: $70.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,385.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $545.84 | 2020-2024 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $489.08 | 2021-2024 | |
| Lilly USA, LLC | $409.21 | 2021-2024 | Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $305.21 | 2022-2024 | Breztri, Farxiga, Airsupra |
| Pfizer INC. | $284.45 | 2021-2025 | |
| Amgen INC. | $243.94 | 2019-2024 | Evenity, Prolia, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $102.26 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $99.88 | 2020-2023 | Xarelto |
| Astellas Pharma US INC | $94.95 | 2022-2024 | Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $89.59 | 2022-2023 | Belsomra, Steglatro |
| Exact Sciences Corporation | $87.88 | 2023-2024 | Cologuard Collection Kit |
| Alexion Pharmaceuticals, INC. | $87.70 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.12 | 2023-2024 | Ofev, Jardiance, Synjardy |
| Alnylam Pharmaceuticals INC. | $74.52 | 2023-2024 | Amvuttra, Onpattro |
| Daiichi Sankyo INC. | $67.20 | 2024 | Injectafer |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Goldberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.